 NEW YORK and BERLIN, March 23, 2022 GLOBE NEWSWIRE -- atai Life Sciences N.V. Nasdaq: ATAI atai, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it plans to host a webcast on Wednesday, March 30, 2022 at 8:30 a.m. ET to discuss its financial results for the fourth quarter 2021 and provide a business update. 